[Seite 94↓]


Adgey, A.: An overview of the results of clinical trials with Glykoprotein IIb/IIIa inhibitors. Am Heart J 1998; 135(4): 43-55.

Aldermann, H.M., Madhava n, S. et al.: Association of the renin-sodium profil with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104.

Al-Saady, N., Leatham, E., Gupta , S.: Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure. Heart 1999, 81:134-140.

Altieri, D.C., Edgington, T.S . et al.: A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (MAC-1), J of Immunology 1988, 141(8): 2656-2660.

Ammon C., Meyer, S . et al.: Comparitive analysis of integrin expression on monocyte derived macophages and monocyte derived dendritic cells. Immunology 2000; 100: 364-369.

Arkin, S., Naprstek, B. et al.: Expression of intercellular adhesion molecule-1 (CD54) on hematopoetic progenitors. Blood 1991; 77: 948-953.

Bader, M., Peters, J. et al.: Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001; 79(2-3):76-102.

Bataillard, A., Renaudin, C. et al.: Silica attenuates hypertension in Lyon hypertensive rats. J Hypertens 1995; 13: 1581-1584.

Bendas, G.: Selektine als neue Zielstrukturen für die Pharmaforschung. internet 1999, GOVI-Verlag.

Buemi, M., Allegra, A., Aloisi, C.: Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-Selectin in normotensive and hypertensive patients. Hypertension 1997; 30: 845-847.

[Seite 95↓]

CAPTURE Study: Randomised placebo-controll trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet 1997; May 17; 349 (9063): 1429-1435.

Carlos, T., Kovach, N. et al : Human monocyte bind to two cytocine-induced adhesive ligands on cultured human endothelial cells. Blood 1991; 77 (10): 2266-2271.

Chae, C.U., Lee, R.T. et al . : Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38(3): 399-403.

Cheng, J., Wung, B. et al.: Cyclic strain enhances adhesion of monocytes to endothelial cells by increasing intercellular adhesion molecule-1 expression. Hypertension 1996, 28: 386-391.

Clozel, M., Kuhn, H., Hefti, F.: Endothelial dysfunktion and subendothelial monocyte macrophages in hypertension, Hypertension 1991; 18: 132-134.

Coller, B.S. et al.: Potential non-Glykoprotein IIb/IIIa effects of abciximab, Am Heart J 1999; 138(1 Pt 2): 1-5.

Couffinthal, T., Duplaa, C. et al.: Effect of low density lipoprotein on monocyte adhesiveness to endothelial cells in vitro. Atherosclerosis 1999; 93: 35- 45.

Cronstein, B.N., Kimel, S.C. et al.: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1992; 89(21): 9991-9995.

DeBount, N., Geijtenbeek, T., Ntea, M.: Integrin mediated adhesion of mononuclear cells from patients with hypercholemia. Eur J Clin Invest 1999, 29(9): 749 -57.

Dechend, R., Homuth, V., Wallukat, G.: AT1 Rezeptor agonist antibodies from preeclamptic patients cause vascular cells to express tissue factor, Franz Volhard Clinic, Berlin, Circulation 2000; 101: 2382-2393.

[Seite 96↓]

DeGasparo, M., Catt, K.J. et al.: International Union of Pharmacology.XXIII . The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472.

DeSouza, C., Dengel, D., Macko, R.: Elevated levels of circulating cell adhaesions molecules in uncomplicated essential hypertension. J Hypertens 1997; 10:1335-1341.

Deutsche Hochdruckliga, Stellungsnahme zur aktuellen Diskussion über die medikamentöse Hochdrucktherapie. Juni 2003, Therapieempfehlungen Nov. 2002, Homepage der Deutsche Hochdruckliga.

Dörffel, Y.: Rolle peripherer Monozyten bei Patienten mit essentieller Hypertonie. Habilitation. 2002. HU-Berlin.

Dörffel, Y., Franz, St., Pruß, A., Neumann, G., Rhode, W., Burmester, G., Scholze, J.: Preactivated monocytes from hypertensive patients as a factor for atheroclerosis? Atherosclerosis 157 , 2001 : 151-160 .

Dörffel, Y., Lätsch, Ch. Stuhlmüller, B., Schreiber, St., Scholze, S., Burmester, G., Scholze, J.: Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999; 34 :113-117.

Dougherty, G.J., Murdoch, S., Hogg, N.: The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an imune response. Eur. J. Immunol. 1988; 18: 35-39.

Faas, M., Schuiling, G., Linton , E.: Activation of peripheral leucocytes in rat pregnancy and experimental preeclampsia. Am J of Obstetrics and Gynecology 2000, 182: 351-357.

Frederickson; B.J.; Turner; N.A. et al.: Effects of abciximab, ticlopidine, and combined abicimab/ticlopidine therapy on platelet and leucocyte function in patients undergoing coronary angioplasty, Circulation 2000, 101(10):1122-1137.

Fritsch, P.: Dermatologie und Venerologie. Springer 1998.

[Seite 97↓]

Fu, M.L. et al.: Autoantibodies against angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000; 18: 945-953.

Fukai, T., Siegfried, M. et al.: Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 1999, 85: 23-28.

Hahn A.W.A., Jonas, F., Bühler F.R., Resink, T.J.: Activation of human peripheral monocytes by angiotensin II. FEBS Lett 1994; 347: 178-180.

Hamm, C. Neue Thrombozytenaggregationshemmer in der Therapie der instabilen Angina. Z Kardiol 2000; 89: 1053-1056.

Haugen, T. S., Skjonsberg, O., Nakstad, B.: Modulation of adhesion molecule profiles on alveolar macrophages and blood leukocytes. Respiration 1999, Nov. 66(6): 528-37.

Hentzen, E.R., Neelamegham, S. et al.:, Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule- 1Blood 2000, 95(3): 911-920.

Hilme, E. , Hansson, L. et al.: Abnormal immune function in malignant hypertension. J Hypertens 1993; 11: 989-994.

Homuth, V., Dechend, R. et al.: Autoantikörper gegen den Angiotensin AT1-Rezeptor sind im Tiermodel einer malignen Hypertonie am kardiovaskulären Endorganschaden beteiligt. Workshop . Thieme Verlag. ZGN 2001.

Homuth, V., Wallukat, G. et al.: Charakterisierung von agonistischen Autoantikörpern gegen den AT1-Rezeptor bei Patientinnen mit Präeklampsie und HELLP-Syndrom. Speculum 2000, 18: 6-14.

JNC-VII (Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure) 2003, JNC-VI 1997, Report vom Server des National Heart Lung and Blood Institute.

[Seite 98↓]

Kalra, V.K., Ying, Y. et al. : Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultered endothelial cells. J Cell Physiol 1994; 160: 154-162.

Kannel, W.B.: Epidemiology of coronary atherosclerosis: post mortem vs clinical risk factors correlations. The Framingham Study. In: Gotto AM Jr, Smith L. Atherosclerosis. Springer Verlag, New York, 1980: 54-56.

Keidar, S.: Angiotensin, LDL peroxidation and atherosclerosis. Life Sci 1998; 63: 1-11.

Kereiakes, D.J., Runyon, J. P. et al.: IIb’s are not IIb’s, The American Journal of Cardiology 2000, 85(8 Supplement1): 23-31.

Kleimann, N.S. et al.: A risk-benefit assesment of abciximab in angioplasty, Drug Saf 1999, 20(1): 43-45.

Kiarash, A., Pagano, P., Tayeh, M.: Upregulated Expression of rat heart intercellular adhesion molecule-1 in angiotensin-II- but not Phenylephrine- induced hypertension. Henry Ford Hospital. Detroit.

Kim, J., Berliner, J., Nadler, J.: Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun 1996 24; 226 (3): 862-868.

Kim, J., Chopp, M., Chen, H.: Adhesive Glykoproteins CD11a and CD18 are upregulated in the leucocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 1995; 128(1):45-50.

Komatsu, S., Panes, J., Russell, J.: Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo. Hypertension 1997; 29: 683-689.

Konstantopoulus, K., Neelamegham, S. et al.: Venouse levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and β 2-integrin, Circulation 1998; 98: 873-882.

[Seite 99↓]

Kranzhöfer, R., Browatzki, M. et al.: Angiotensin II activates the proinflammatory transcription factor nuclear factor κ B in human monocytes. Biochemical and Biophysical Resarch Communications 1999, 253: 826-828.

Kubitschek, J. H.: HOPE-Studie, ACE Hemmer RAMIPRIL revolutioniert die Herztherapie. Bericht vom Kongreß der AHA. Internet 2000.

Landmann, R., Scherer, F. et al.: LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. J Leukoc Biol 1995; 57: 440-449.

Lang, R., Karow, Th.: Allgemeine und spezielle Pharmakologie und Toxikologie. Bergisch- Gladbach. 2000.

Langstein, J., Becke, F.M., Sollner, L. et al.: Comparative analysis of CD137 and LPS effects on monocyte activation, survival and proliferation. Biochem Biophys Res Commun 2000; 273:117-122.

Lenter, M., Uhlig, H., Hamann, A.: A monoclonal antibody against activation epitope on mouse integrin chain β 1 blocks adhesion of lymphocytes to the edothelial integrin α 6 β 1. Cell Biology 1993; 90: 9051-55.

Leung, P.S., Tsai, S.J., Wallukat, G. et al.: The upregulation of angiotensin II receptor AT(1) in human preeclamtic placenta. Mol Cell Endocrinol 2001; 184(1-2):95-102.

Ley, K.: Molecular mechanisms of leukocyte recruitement in the inflamatory process. Cardiovasc Res 1996; 32(4):733-742.

Ley, K.: Selektine und Integrine bei Ischämie und Arteriosklerose. Vortrag Deutsches Rheumaforschungszentrum.Berlin 2001.

Lilly : Firmeninformation : http://www.reopro.com/US/science/

Linz, W. : Long-term angiotensin II type 1 receptor blockade doubles lifespan of hypertensive rats. Hypertension 2000; 35: 908.

[Seite 100↓]

Liu, Y., Liu, T., McCarron R., Spatz, M.: Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol 1996 Jun, 270: H2125-2131.

Lo, S., Cheung, A., Zheng, Q.: Induction of tissue factor on monocytes by adhesion to endothelial cells. J of Immunology 1995, 154: 4768-4777.

Lopes-Virella, M. et al.: Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunology 1985; 37: 377-386.

Lüschner, T., Noll, G. et al.: The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995; 118:81-90

Luft, F.C.: Angiotensin, inflammation, hypertension, and cardivascular disease. Curr Hypertens Rep 2001; 3(1): 61-67.

Luft, F.C .: Hypertension as a complexe genetic trait . Semin Nephrol 2002; 22(2):115-126.

Lundahl, J., Skold, C. et al.: Monocyte and neutrophil adhesion to matrix proteins is selectivly enhanced in the presence of inflammatory mediators. Scand J Immunol 1996 Aug ; 44(2): 143-149.

Luscinskas, F. et al.: Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-Selektin, β 1 Integrins and β 2 integrins. J of cell biology 94; 125: 1417-1427.

Luther, H., Homuth, V., Wallukat, G. et al.: Alpha-1–adrenergic receptor antibodies in patients with primary hypertension. Hypertension. 1997, 29(2): 678-82.

Macey, M., McCarthy, D. et al. : Effects of cell purification methods on CD11b and L-Selektin expression as well as the adherence and activation of leucocytes . J Immunol Methods 1995; 181(2):211-219.

Masuda, M., Takahashi,H. et al.: Adhesion of leukocytes to endothelial cells in artherosclerosis. Rinsho Byori 1998 Nov, 46(11): 1149-1155.

[Seite 101↓]

McCarron, R., Wang, L., Siren, A.: Monocyte adhesion to cerebrovascular endothelial cells derived from hypertensive and normotensive rat. Am J Physiol 1994; 267: H2491-H2497.

Meniconi, A. et al.: Ist die Arteriosklerose eine Infektionskrankheit? Praxis 1998; 87: 64-74.

Meisel, S., Shapiro H., Radnay, J.: Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and MAC-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. J Am Coll Cardiol 1998; 31(1):120-125.

Mervaala, E.M., Muller, D. et al.: Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Franz Volhard Clinic. Hypertension 1999, 33, 1Pt 2: 389-395.

Mervaala, E.M., Muller, D., Dechend, R. et al.: Cycolsporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. Hypertension 2000; 35: 360-366.

Mickelson, J.K., Ali, M.N. et al.: Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutophils from patients undergoing coronary angioplasty, JACC 1999; 33(1): 97-106.

Mills, P., Farag, N. et al.: Peripheral blood mononuklear cell CD62L and CD11a expression and soluble interstitial cell adhesion molecule-1 levels following infused isoproterenol in hypertension. J Hypertension 2002; 20 (2): 311-316.

Muller, D., Dechend, R. et al.: Angiotensin-induced inflammation and novel approaches to treatment. Adv Nephrol Necker Hosp 2001; 31: 89-103.

Muller D., Heissmeyer, V. et al.: Aspirin inhibits NF- κ B and protects from angiotensin II-induced organ damage . Faseb Journal 2001, 15 (10):1822-1828

Muller, D.N., Mervaala, E.M., Luft, F.C. et al.: Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002 Nov; 161(5):1679-1693.

[Seite 102↓]

Muller, W.A., Randolph, G.J. et al.: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes.J Leukoc Biol 1999 Nov; 66(5): 698-704. Review.

Nagata, K. et al.: Effects of blockade of the renin – agingiotensin system on tissue factor and plasminogen activator-1 synthesis in human cultured monocytes. J Hypertens 2001; 19: 776-789.

Nakashima, Y. et al.: Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites. Arterioslerosis, Thrombosis and vascular biology. 1998; 18: 842-851.

Neumann, F.J., Zohlnhofer D. et al.: Effect of Glykoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin MAC-1 in acute myocardial infarction , J Am Coll Cardiol 1999; 34 (5):1420-1426.

Nickening, G. , Böhm, M. et al.: Bedeutung des Angiotensin-II-Rezeptors AT1 für die Ent-stehung von arterieller Hypertonie und Arteriosklerose. Dtsch. med. Wschr. 1997; 122: 1009-1013.

Plescia, J., Conte, M.S. et al.: Molecular identification of the cross-reacting epitope on α M β 2 Integrin I Domain recognized bei the Anti- α IIb β 3 monoclonal antibody 7E3 and its involvement in leucocyte adherence. J of Biological Chemistry 1998, 273(32): 20372-20377.

Potter, D. D., Sobey C.G. et al.: Evidence that macrophages in atherosclerotic lesions contain Angiotensin II. Circulation 1998; 98: 800-807.

Randolph, G.J. , Luther, T., Muller, et al.: Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998; 92(11): 4167-4177.

Roitt, I, Brostoff, J., Male, D.: Immunology. Mosby-Verlag. London 1998.

Ross, R.: The pathogenesis of atherosclerosis: a perspectiv for the 1990s. Nature. 1993; 362: 801-809.

Ross, R.: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 38: 71-79

[Seite 103↓]

Rubio, M., Sotillos, M., Jochems, G. et al.: Monocyte activation: rapid induction of α 1/ β (VLA4) integrin expression by LPS and interferon. Eur J Immunol. 1995; 25 :2701-2705.

Scannell, G., Waxmann, K. et al.: Hypoxia-induced alteration of neutrophil membrane receptors. J Surg Res 1995; 59: 141-145.

Schmitz, G., Herr, Rothe et al.: T-Lymphozyten und Monozyten in der Pathogenese der Arteriosklerose. Herz 1998; 23: 168–177.

Scholze, J.: Hypertonie. Risikokonstellationen und Begleiterkrankungen. Blackwell Wissenschaftsverlag. Berlin, Wien 1999.

Shen, Y., Rattan, V.: Cigarette smoke condensate-induced adhesion molecule expression and transmigration of monocytes. Am J Physiol 1996; 270: H1624-1633.

Simon, B., Noll, Maisch et al.: Endotheliale Dysfunktion - eine Bestandsaufnahme und Ansätze zur Therapie. Herz 1999; 24: 62 – 71.

Simon, D.I., Xu, H. et al. : 7 E3 monoclonal antibody directed against the platelet Glykoprotein IIb/IIIa cross-reacts with the leucocyte integrin MAC-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 1997; 17(3): 528-535.

Spiering, W, Kroon, A. et al.: Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000, 36: 411-416.

Stent, G., Crowe, S.M. et al.: Effects of monocyte purification and culture on integrin expression. APMIS 1997; 105: 663-670.

Stohlawetz, P., Hahn, P., Koller, M.: Immunophenotypic characterisatics of monocytes in elderly subjects. Scand J Immunol 1998; 48(3): 324-326.

[Seite 104↓]

Strawn, W., Gallagher, P., Talant, E.: Angiotensin II AT 1–Rezeptor blockade inhibits monocyte activation and adherence in transgenetic (mRen2)27 rats. J of Cardiovascular pharmacology 1999; 33: 341-351.

Suzuki, K., Masawa, N. et al.: The pathogenesis of cerebrovascular lessions in hypertensive rats. Med Elektron Microsc 2001; 34(4): 230-239.

Theuer, J., Dechend, R. et al.: Angiotensin II induced inflammation in the kidney and the heart of double transgenic rats. BMC Cardiovascular Disorders 2002, 2:3.

Tsao, Ph. et al.: Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioslerosis, Thrombosis and vascular biology 1998; 18: 947-953.

Tummala, P., Chen, X., Sundell, C.: Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculatur. Circulation 1999; 100: 1223-1229.

Violi, F. et al.: Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease . Results from the A.D.E.P. study. Atherosclerosis 1996; 120: 25-35.

Vogel, R.A.: Coronary risk factors, endothelial function and atherosclerosis. Clin. Cardiol. 1997; 20: 426-432.

Wallukat, G., Homuth, V., Fischer, TH. et al.: Patients with preeclampsia develop agonist autoantibodies against the angiotensin AT1 Rezeptor, J Clin Invest 1999; 103: 945-952.

Wambach, G., Fritschka, E.: Arterielle Hypertonie und vaskuläres System. Upjohn GmbH. 1994

WHO/ISH: Guidelines for Management of Hypertension. J of Hypertension 1999; 17(1): 151-183.

[Seite 105↓]

Wick, G. et al.: Is arteriosclerosis an immunologically mediated disease? Immunol Today 1995; 16(1): 27-33.

Xiong, H. et al.: The expression of CD11a and CD11b on leucocytes in cerebral thrombosis, Hua Xi Yi Ke Da Xue Xue Bao. 1998 Dec; 29(4): 415-417.

Yusuf, S., Sleight P. et al.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; Jan 20, 342(3): 145-153.

[Seite 106↓]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: